Το Γενικό Λαϊκό Νοσοκομείο Αθηνών είναι ελληνικό τριτοβάθμιο δημόσιο πανεπιστημιακό νοσηλευτικό ίδρυμα, ενταγμένο στο Ε.Σ.Υ. Το ίδρυμα υπάγεται στην 1η Υ.ΠΕ. Αττικής. Διαθέτει πολλές Κλινικές, Εργαστήρια, Τμήματα και Εξωτερικά Ιατρεία. Στεγάζεται επί της οδού Αγίου Θωμά 17, Τ.Κ. 11527, στην Αθήνα.

During the past decade, "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine" #1 sponsor was "Hellenic Oncology Research Group" with 40 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "National and Kapodistrian University of Athens" with 7 trials sponsored, "Hellenic Institute for the Study of Sepsis" with 5 trials sponsored and "Hellenic Cooperative Oncology Group" with 5 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine" #1 collaborator was "University Hospital of Crete" with 32 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Harvard Medical School (HMS and HSDM)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine" are "Breast Cancer" (14 trials), "Non Small Cell Lung Cancer" (8 trials), "Non-small-cell Lung Cancer" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials) and "Non-Hodgkin's Lymphoma" (3 trials). Many other conditions were trialed in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine" in a lesser frequency.

Most popular intervention types in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine" are "Drug" (59 trials), "Other" (5 trials), "Radiation" (2 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (18 trials), "Bevacizumab" (13 trials), "Gemcitabine" (11 trials), "Carboplatin" (8 trials) and "Vinorelbine" (8 trials). Other intervention names were less common.

The vast majority of trials in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine" are 48 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in ""Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine, 7 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".